[HTML][HTML] Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies

RE Rossi, A Elvevi, D Citterio, J Coppa… - World journal of …, 2021 - ncbi.nlm.nih.gov
Zollinger-Ellison syndrome (ZES) associated with pancreatic or duodenal gastrinoma is
characterized by gastric acid hypersecretion, which typically leads to gastroesophageal …

[HTML][HTML] Gastrinoma

RT Jensen, T Ito - Endotext [Internet], 2023 - ncbi.nlm.nih.gov
Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

J Hofland, M Falconi, E Christ… - Journal of …, 2023 - Wiley Online Library
This ENETS guidance paper aims to provide practical advice to clinicians for the diagnosis,
treatment and follow‐up of functioning syndromes in pancreatic neuroendocrine tumours …

Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies

L Lee, T Ito, RT Jensen - Expert review of anticancer therapy, 2019 - Taylor & Francis
Introduction: Recent advances in diagnostic modalities and therapeutic agents have raised
the importance of prognostic factors in predicting overall survival, as well as predictive …

Management of functional pancreatic neuroendocrine neoplasms

L Magi, M Marasco, M Rinzivillo, A Faggiano… - … Treatment Options in …, 2023 - Springer
Opinion statement Functional pancreatic neuroendocrine neoplasms (pNENs) are rare and
heterogeneous diseases in terms of both clinical and pathological aspects. These tumors …

Insights into effects/risks of chronic hypergastrinemia and lifelong ppi treatment in man based on studies of patients with Zollinger–Ellison syndrome

L Lee, I Ramos-Alvarez, T Ito, RT Jensen - International Journal of …, 2019 - mdpi.com
The use of proton pump inhibitors (PPIs) over the last 30 years has rapidly increased both in
the United States and worldwide. PPIs are not only very widely used both for approved …

[HTML][HTML] Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies

QQ Shao, BB Zhao, LB Dong, HT Cao… - World Journal of …, 2019 - ncbi.nlm.nih.gov
Zollinger-Ellison syndrome (ZES) is characterized by gastric acid hypersecretion causing
severe recurrent acid-related peptic disease. Excessive secretion of gastrin can now be …

[HTML][HTML] Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors

JL Buicko, BM Finnerty, T Zhang, BJ Kim… - Annals of pancreatic …, 2019 - ncbi.nlm.nih.gov
Pancreatic neuroendocrine tumors (PNETs) are the second most common primary
pancreatic neoplasms after pancreatic ductal adenocarcinoma. PNETs present with widely …

Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1

MB Albers, J Manoharan, DK Bartsch - Best Practice & Research Clinical …, 2019 - Elsevier
About 30% of patients with MEN1 develop a Zollinger-Ellison syndrome. Meanwhile it is well
established that the causative gastrinomas are almost exclusively localized in the …

[HTML][HTML] Gastrinoma in multiple endocrine neoplasia type 1 after total pancreatectomy: a case report

S Gong, Z Li, XB Liu, X Wang, WW Shen - Medicine, 2019 - journals.lww.com
Gastrinoma in multiple endocrine neoplasia type 1 after tota... : Medicine Gastrinoma in
multiple endocrine neoplasia type 1 after total pancreatectomy: A case report : Medicine Log …